Tianyikang Biotechnology Company
Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2024-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
Gene Therapies (Diseases Treatment)
Investors:
Addor Capital, Med-Fine Capital, Suzhou Innovation Investment Group, Hony Capital, CS Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China